IDEAS home Printed from https://ideas.repec.org/f/pse221.html
   My authors  Follow this author

Catherine Sermet

(We have lost contact with this author. Please ask them to update the entry or send us the correct address or status for this person. Thank you.)

Personal Details

First Name:Catherine
Middle Name:
Last Name:Sermet
Suffix:
RePEc Short-ID:pse221
The above email address does not seem to be valid anymore. Please ask Catherine Sermet to update the entry or send us the correct address or status for this person. Thank you.
http://www.irdes.fr/EspaceRecherche/Equipe/Sermet.htm

Affiliation

Institut de Recherche et Documentation en Économie de la Santé (IRDES)

Paris, France
https://www.irdes.fr/
RePEc:edi:credefr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
  2. Christine Sorasith & Sylvain Pichetti & Thomas Cartier & Laure Bergua & Catherine Sermet, 2012. "Déterminants de l’écart de prix entre médicaments similaires et le premier entrant d’une classe thérapeutique," Working Papers DT43, IRDES institut for research and information in health economics, revised Feb 2012.
  3. Nathalie Grandfils & Catherine Sermet, 2009. "Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom," Working Papers DT21, IRDES institut for research and information in health economics, revised Feb 2009.
  4. Sandy Tubeuf & Florence Jusot & Marion Devaux & Catherine Sermet, 2008. "Social heterogeneity in self-reported health status and measurement of inequalities in health," Working Papers DT12, IRDES institut for research and information in health economics, revised Jun 2008.
  5. Florence Jusot & Jérôme Silva & Paul Dourgnon & Catherine Sermet, 2008. "Etat de santé des populations immigrées en France," Working Papers DT14, IRDES institut for research and information in health economics, revised Jul 2008.

Articles

  1. Bonny Parkinson & Catherine Sermet & Fiona Clement & Steffan Crausaz & Brian Godman & Sarah Garner & Moni Choudhury & Sallie-Anne Pearson & Rosalie Viney & Ruth Lopert & Adam Elshaug, 2015. "Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review," PharmacoEconomics, Springer, vol. 33(9), pages 905-924, September.
  2. Sylvain Pichetti & Catherine Sermet & Brian Godman & Stephen Campbell & Lars Gustafsson, 2013. "Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France," Applied Health Economics and Health Policy, Springer, vol. 11(3), pages 205-218, June.
  3. Pichetti, Sylvain & Sorasith, Christine & Sermet, Catherine, 2011. "Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010," Health Policy, Elsevier, vol. 102(2), pages 159-169.
  4. Florence Jusot & Jérôme Silva & Paul Dourgnon & Catherine Sermet, 2009. "Inégalités de santé liées à l'immigration en France. Effet des conditions de vie ou sélection à la migration ?," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 385-411.
  5. Khlat, Myriam & Sermet, Catherine & Le Pape, Annick, 2000. "Women's health in relation with their family and work roles: France in the early 1990s," Social Science & Medicine, Elsevier, vol. 50(12), pages 1807-1825, June.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.

    Cited by:

    1. Ana Beatriz D′Avó Luís & Mikyung Kelly Seo, 2021. "Has the development of cancer biomarkers to guide treatment improved health outcomes?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 789-810, July.
    2. Mohamed Ali Ben Halima & Thierry Debrand & Camille Regaert, 2012. "Sick Leaves: Understanding Disparities Between French Departments," Working Papers DT50, IRDES institut for research and information in health economics, revised Oct 2012.
    3. Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.

  2. Christine Sorasith & Sylvain Pichetti & Thomas Cartier & Laure Bergua & Catherine Sermet, 2012. "Déterminants de l’écart de prix entre médicaments similaires et le premier entrant d’une classe thérapeutique," Working Papers DT43, IRDES institut for research and information in health economics, revised Feb 2012.

    Cited by:

    1. Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.

  3. Nathalie Grandfils & Catherine Sermet, 2009. "Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom," Working Papers DT21, IRDES institut for research and information in health economics, revised Feb 2009.

    Cited by:

    1. Thierry Debrand & Nicolas Sirven, 2009. "What are the Motivations of Pathways to Retirement in Europe: Individual, Familial, Professional Situation or Social Protection Systems?," Working Papers DT28, IRDES institut for research and information in health economics, revised Oct 2009.
    2. Nicolas Gérard Vaillant & François-Charles Wolff, 2010. "Origin differences in self-reported health among older migrants living in France," Working Papers hal-00449608, HAL.
    3. Thierry Debrand & Christine Sorasith, 2010. "Out-of-Pocket Maximum Rules under a Compulsatory Health Care Insurance Scheme: A Choice between Equality and Equity," Working Papers DT34, IRDES institut for research and information in health economics, revised Nov 2010.

  4. Sandy Tubeuf & Florence Jusot & Marion Devaux & Catherine Sermet, 2008. "Social heterogeneity in self-reported health status and measurement of inequalities in health," Working Papers DT12, IRDES institut for research and information in health economics, revised Jun 2008.

    Cited by:

    1. Thierry Debrand & Nicolas Sirven, 2009. "What are the Motivations of Pathways to Retirement in Europe: Individual, Familial, Professional Situation or Social Protection Systems?," Working Papers DT28, IRDES institut for research and information in health economics, revised Oct 2009.
    2. Eve Caroli & Mathilde Godard, 2016. "Does job insecurity deteriorate health?," PSE-Ecole d'économie de Paris (Postprint) halshs-01311366, HAL.
    3. Caroli, Eve & Godard, Mathilde, 2014. "Does Job Insecurity Deteriorate Health? A Causal Approach for Europe," IZA Discussion Papers 8299, Institute of Labor Economics (IZA).
    4. Eve Caroli & Lexane Weber-Baghdiguian, 2016. "Self-reported health and gender: The role of social norms," Post-Print halshs-01379374, HAL.
    5. Nunzia Nappo, 2019. "Is there an association between working conditions and health? An analysis of the Sixth European Working Conditions Survey data," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-15, February.
    6. Zeynep Or & Chantal Cases & Melanie Lisac & Karsten Vrangbaek & Ulrika Winblad & Gwyn Bevan, 2009. "Are Health Problems Systemic? Politics of Access and Choice under Beveridge and Bismarck Systems," Working Papers DT27, IRDES institut for research and information in health economics, revised Sep 2009.
    7. Marion Devaux, 2015. "Income-related inequalities and inequities in health care services utilisation in 18 selected OECD countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 21-33, January.
    8. Florence Jusot & Sabine Mage-Bertomeu & Marta Menéndez, 2017. "Inequality of Opportunity in Health in Indonesia," Working Papers hal-01507738, HAL.
    9. DEUTSCH Joseph & PI ALPERIN Maria Noel & SILBER Jacques, 2016. "Disentangling the impacts of circumstances and efforts on health inequality: the case of Luxembourg," LISER Working Paper Series 2016-07, Luxembourg Institute of Socio-Economic Research (LISER).
    10. Dourgnon, Paul, 2013. "Evaluation des politiques publiques et inégalités sociales d'accès aux services de santé," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/12221 edited by Wittwer, Jérôme.
    11. Emmanuelle Cambois & Aïda Solé-Auró & Jean-Marie Robine, 2019. "Gender Differences in Disability and Economic Hardship in Older Europeans," European Journal of Population, Springer;European Association for Population Studies, vol. 35(4), pages 777-793, October.
    12. Joseph Deutsch & María Noel Pi Alperin & Jacques Silber, 2018. "Using the Shapley Decomposition to Disentangle the Impact of Circumstances and Efforts on Health Inequality," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 138(2), pages 523-543, July.
    13. Emmanuelle Cambois & Caroline Laborde & Isabelle Romieu & Jean-Marie Robine, 2011. "Occupational inequalities in health expectancies in France in the early 2000s: Unequal chances of reaching and living retirement in good health," Demographic Research, Max Planck Institute for Demographic Research, Rostock, Germany, vol. 25(12), pages 407-436.
    14. María Noel Pi Alperin, 2016. "A multidimensional approach to measure health," Economics Bulletin, AccessEcon, vol. 36(3), pages 1553-1568.

  5. Florence Jusot & Jérôme Silva & Paul Dourgnon & Catherine Sermet, 2008. "Etat de santé des populations immigrées en France," Working Papers DT14, IRDES institut for research and information in health economics, revised Jul 2008.

    Cited by:

    1. Boulogne, Roxane & Jougla, Eric & Breem, Yves & Kunst, Anton E. & Rey, Grégoire, 2012. "Mortality differences between the foreign-born and locally-born population in France (2004–2007)," Social Science & Medicine, Elsevier, vol. 74(8), pages 1213-1223.
    2. Emmanuel Cohen & Norbert Amougou & Amandine Ponty & Juliette Loinger-Beck & Téodyl Nkuintchua & Nicolas Monteillet & Jonathan Y. Bernard & Rihlat Saïd-Mohamed & Michelle Holdsworth & Patrick Pasquet, 2017. "Nutrition Transition and Biocultural Determinants of Obesity among Cameroonian Migrants in Urban Cameroon and France," IJERPH, MDPI, vol. 14(7), pages 1-23, June.

Articles

  1. Bonny Parkinson & Catherine Sermet & Fiona Clement & Steffan Crausaz & Brian Godman & Sarah Garner & Moni Choudhury & Sallie-Anne Pearson & Rosalie Viney & Ruth Lopert & Adam Elshaug, 2015. "Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review," PharmacoEconomics, Springer, vol. 33(9), pages 905-924, September.

    Cited by:

    1. Lei Chen & Ying Yang & Mi Luo & Borui Hu & Shicheng Yin & Zongfu Mao, 2020. "The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China," IJERPH, MDPI, vol. 17(24), pages 1-11, December.
    2. Peter Ghijben & Yuanyuan Gu & Emily Lancsar & Silva Zavarsek, 2018. "Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review," PharmacoEconomics, Springer, vol. 36(3), pages 323-340, March.
    3. Peter Ghijben & Dennis Petrie & Silva Zavarsek & Gang Chen & Emily Lancsar, 2021. "Healthcare Funding Decisions and Real-World Benefits: Reducing Bias by Matching Untreated Patients," PharmacoEconomics, Springer, vol. 39(7), pages 741-756, July.
    4. Sabine Vogler & Peter Schneider & Nina Zimmermann, 2019. "Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing," PharmacoEconomics - Open, Springer, vol. 3(3), pages 303-309, September.
    5. Livio Garattini & Alessandro Curto, 2016. "Performance-Based Agreements in Italy: ‘Trendy Outcomes’ or Mere Illusions?," PharmacoEconomics, Springer, vol. 34(10), pages 967-969, October.
    6. Craig Mitton & Brayan V. Seixas & Stuart Peacock & Michael Burgess & Stirling Bryan, 2019. "Health Technology Assessment as Part of a Broader Process for Priority Setting and Resource Allocation," Applied Health Economics and Health Policy, Springer, vol. 17(5), pages 573-576, October.
    7. Sabine Vogler & Valérie Paris & Alessandra Ferrario & Veronika J. Wirtz & Kees Joncheere & Peter Schneider & Hanne Bak Pedersen & Guillaume Dedet & Zaheer-Ud-Din Babar, 2017. "How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 307-321, June.
    8. Hofmann, Bjørn, 2020. "Biases distorting priority setting," Health Policy, Elsevier, vol. 124(1), pages 52-60.
    9. Angelo Claudio Palozzo & Andrea Messori, 2016. "Comment on: “Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review”," PharmacoEconomics, Springer, vol. 34(4), pages 419-420, April.
    10. Viviane Cássia Pereira & Jorge Otávio Maia Barreto & Francisco Assis da Rocha Neves, 2019. "Health technology reassessment in the Brazilian public health system: Analysis of the current status," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-18, July.
    11. Rotteveel, A.H. & Reckers-Droog, V.T. & Lambooij, M.S. & de Wit, G.A. & van Exel, N.J.A., 2021. "Societal views in the Netherlands on active disinvestment of publicly funded healthcare interventions," Social Science & Medicine, Elsevier, vol. 272(C).
    12. Hye-Young Kwon & Brian Godman, 2017. "Drug Pricing in South Korea," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 447-453, August.
    13. Livia Lovato Pires de Lemos & Augusto Afonso Guerra Júnior & Marisa Santos & Carlos Magliano & Isabela Diniz & Kathiaja Souza & Ramon Gonçalves Pereira & Juliana Alvares & Brian Godman & Marion Bennie, 2018. "The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil," PharmacoEconomics, Springer, vol. 36(2), pages 161-173, February.
    14. Karin Dam Petersen & Gang Chen & Christine Mpundu-Kaambwa & Katherine Stevens & John Brazier & Julie Ratcliffe, 2018. "Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 11(1), pages 29-37, February.

  2. Sylvain Pichetti & Catherine Sermet & Brian Godman & Stephen Campbell & Lars Gustafsson, 2013. "Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France," Applied Health Economics and Health Policy, Springer, vol. 11(3), pages 205-218, June.

    Cited by:

    1. Mondelo-García, Cristina & Mendoza, Elvia & Movilla-Fernández, María-Jesús & Coronado, Carmen, 2018. "Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study," Health Policy, Elsevier, vol. 122(12), pages 1316-1325.
    2. Laura V Minard & Amber Corkum & Ingrid Sketris & Judith Fisher & Ying Zhang & Ahmed Saleh, 2016. "Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-15, July.
    3. Bonny Parkinson & Catherine Sermet & Fiona Clement & Steffan Crausaz & Brian Godman & Sarah Garner & Moni Choudhury & Sallie-Anne Pearson & Rosalie Viney & Ruth Lopert & Adam Elshaug, 2015. "Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review," PharmacoEconomics, Springer, vol. 33(9), pages 905-924, September.

  3. Pichetti, Sylvain & Sorasith, Christine & Sermet, Catherine, 2011. "Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010," Health Policy, Elsevier, vol. 102(2), pages 159-169.

    Cited by:

    1. Thengilsdottir, G. & Gardarsdottir, H. & Almarsdottir, A.B. & McClure, C.B. & Heerdink, E.R., 2013. "The association between lifting an administrative restriction on antidepressant dispensing and treatment patterns in Iceland," Health Policy, Elsevier, vol. 111(2), pages 193-199.
    2. Bonny Parkinson & Catherine Sermet & Fiona Clement & Steffan Crausaz & Brian Godman & Sarah Garner & Moni Choudhury & Sallie-Anne Pearson & Rosalie Viney & Ruth Lopert & Adam Elshaug, 2015. "Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review," PharmacoEconomics, Springer, vol. 33(9), pages 905-924, September.
    3. Sylvain Pichetti & Catherine Sermet & Brian Godman & Stephen Campbell & Lars Gustafsson, 2013. "Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France," Applied Health Economics and Health Policy, Springer, vol. 11(3), pages 205-218, June.

  4. Florence Jusot & Jérôme Silva & Paul Dourgnon & Catherine Sermet, 2009. "Inégalités de santé liées à l'immigration en France. Effet des conditions de vie ou sélection à la migration ?," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 385-411.

    Cited by:

    1. Marlène Guillon & Michel Celse & Pierre-Yves Geoffard, 2018. "Economic and public health consequences of delayed access to medical care for migrants living with HIV in France," Post-Print halshs-01511780, HAL.

  5. Khlat, Myriam & Sermet, Catherine & Le Pape, Annick, 2000. "Women's health in relation with their family and work roles: France in the early 1990s," Social Science & Medicine, Elsevier, vol. 50(12), pages 1807-1825, June.

    Cited by:

    1. Marc Fleurbaey & Stéphane Luchini & Christophe Muller & Erik Schokkaert, 2013. "Equivalent Income And Fair Evaluation Of Health Care," Health Economics, John Wiley & Sons, Ltd., vol. 22(6), pages 711-729, June.
    2. Ji-won Kang & Soong-nang Jang, 2020. "Effects of Women’s Work-Family Multiple Role and Role Combination on Depressive Symptoms in Korea," IJERPH, MDPI, vol. 17(4), pages 1-12, February.
    3. Damien Bricard & Stéphane Legleye & Myriam Khlat, 2017. "Changes in Smoking Behavior over Family Transitions: Evidence for Anticipation and Adaptation Effects," IJERPH, MDPI, vol. 14(6), pages 1-10, June.
    4. Eero Lahelma, 2001. "Towards a structuralist understanding of gender differences in health," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 46(4), pages 217-218, July.
    5. Månsdotter, Anna & Lundin, Andreas, 2010. "How do masculinity, paternity leave, and mortality associate? -A study of fathers in the Swedish parental & child cohort of 1988/89," Social Science & Medicine, Elsevier, vol. 71(3), pages 576-583, August.
    6. Roos, Eva & Burström, Bo & Saastamoinen, Peppiina & Lahelma, Eero, 2005. "A comparative study of the patterning of women's health by family status and employment status in Finland and Sweden," Social Science & Medicine, Elsevier, vol. 60(11), pages 2443-2451, June.
    7. Stefanie Sperlich & Sonja Arnhold-Kerri & Siegfried Geyer, 2011. "What accounts for depressive symptoms among mothers? The impact of socioeconomic status, family structure and psychosocial stress," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 56(4), pages 385-396, August.
    8. Fritzell, Sara & Burstrom, Bo, 2006. "Economic strain and self-rated health among lone and couple mothers in Sweden during the 1990s compared to the 1980s," Health Policy, Elsevier, vol. 79(2-3), pages 253-264, December.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 3 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (2) 2008-07-20 2009-02-22
  2. NEP-LAB: Labour Economics (1) 2008-07-30
  3. NEP-MIG: Economics of Human Migration (1) 2008-07-30

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Catherine Sermet should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.